- Home
- SNX vs KTTA Comparison
SNX vs KTTA Comparison
Compare SNX & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNX | KTTA |
|---|---|---|
| Founded | 1980 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 5.3M |
| IPO Year | 2003 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SNX | KTTA |
|---|---|---|
| Price | $150.80 | $1.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $168.60 | $3.00 |
| AVG Volume (30 Days) | ★ 769.4K | 662.6K |
| Earning Date | 01-08-2026 | 11-13-2025 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ 18.98 | N/A |
| EPS | ★ 9.21 | N/A |
| Revenue | ★ $60,973,509,000.00 | N/A |
| Revenue This Year | $7.25 | N/A |
| Revenue Next Year | $4.35 | N/A |
| P/E Ratio | $16.32 | ★ N/A |
| Revenue Growth | ★ 6.94 | N/A |
| 52 Week Low | $92.23 | $0.28 |
| 52 Week High | $167.76 | $3.85 |
Technical Indicators
Market Signals| Indicator | SNX | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.57 | 65.31 |
| Support Level | $152.32 | $1.09 |
| Resistance Level | $155.06 | $1.21 |
| Average True Range (ATR) | 3.21 | 0.09 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 22.16 | 88.38 |
Price Performance
Historical ComparisonAbout SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).